Literature DB >> 26463405

Alcohol and cigarette smoke components activate human pancreatic stellate cells: implications for the progression of chronic pancreatitis.

Alexandra T K Lee1,2, Zhihong Xu1, Srinivasa P Pothula1, Mishaal B Patel1,2, Romano C Pirola1, Jeremy S Wilson1, Minoti V Apte1.   

Abstract

BACKGROUND: Chronic pancreatitis, a known complication of alcohol abuse, is characterized histopathologically by prominent fibrosis. Pancreatic stellate cells (PSCs) are responsible for producing this fibrous tissue in chronic pancreatitis and are activated by alcohol. Progression of alcoholic chronic pancreatitis (as assessed by calcification and fibrosis) is thought to be facilitated by concurrent smoking, but the mechanisms are unknown. This study aimed to (a) determine whether human PSCs (hPSCs) and rat PSCs express nicotinic acetylcholine receptors (nAChRs), which are known to bind 2 important components of cigarette smoke, namely nicotine and nicotine-derived nitrosamine ketone (NNK), and (b) examine the effects of cigarette smoke components in the presence and absence of alcohol on PSC activation in vitro.
METHODS: Western blotting was used to detect the presence of nAChRs in primary cultures of PSCs. Clinically relevant concentrations of cigarette smoke components (either cigarette smoke extract [CSE], NNK, or nicotine) ± ethanol (EtOH) were used to treat primary cultures of PSCs, and stellate cell activation was assessed by cell migration, proliferation, collagen production, and apoptosis.
RESULTS: We demonstrate, for the first time, that PSCs express nAChRs (isoforms α3, α7, β, ε) and that the expression of the α7 isoform in hPSCs is induced by CSE + EtOH. We also provide novel findings that PSCs are activated by CSE and NNK (both alone and in combination with EtOH) as evidenced by an increase in cell migration and/or proliferation. Further, we demonstrate that activation of PSCs by CSE + EtOH and NNK + EtOH may be mediated via nAChRs on the cells.
CONCLUSIONS: PSCs are activated by clinically relevant concentrations of cigarette smoke components (CSE and NNK), alone and in combination with EtOH. Thus, in alcoholics who smoke, progression of pancreatic fibrosis may be facilitated by the combined effects of alcohol and cigarette smoke components on hPSC behavior.
Copyright © 2015 by the Research Society on Alcoholism.

Entities:  

Keywords:  Alcohol; Chronic Pancreatitis; Pancreatic Fibrosis; Pancreatic Stellate Cells; Smoking

Mesh:

Substances:

Year:  2015        PMID: 26463405     DOI: 10.1111/acer.12882

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  19 in total

Review 1.  Animal models of gastrointestinal and liver diseases. Animal models of acute and chronic pancreatitis.

Authors:  Xianbao Zhan; Fan Wang; Yan Bi; Baoan Ji
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-07-14       Impact factor: 4.052

Review 2.  The deleterious effects of smoking on the development and progression of chronic pancreatitis.

Authors:  Samuel Y Han; Darwin L Conwell; Philip T Diaz; Amy Ferketich; Christie Y Jeon; Dhiraj Yadav; Phil A Hart
Journal:  Pancreatology       Date:  2022-08-11       Impact factor: 3.977

3.  Comparative Analysis of Early Clinical Features and Complications of Different Types of Acute Pancreatitis.

Authors:  Hongsheng Wu; Keqiang Ma; Biling Liao; Tengfei Ji; Shengmin Zhang; Tiansheng Cao
Journal:  Oxid Med Cell Longev       Date:  2022-06-25       Impact factor: 7.310

Review 4.  Pancreatic stellate cells - rising stars in pancreatic pathologies.

Authors:  P Hrabák; M Kalousová; T Krechler; T Zima
Journal:  Physiol Res       Date:  2021-12-30       Impact factor: 2.139

5.  Lifetime and baseline alcohol intakes and risk of pancreatic cancer in the European Prospective Investigation into Cancer and Nutrition study.

Authors:  Sabine Naudin; Kuanrong Li; Tristan Jaouen; Nada Assi; Cecilie Kyrø; Anne Tjønneland; Kim Overvad; Marie-Christine Boutron-Ruault; Vinciane Rebours; Anne-Laure Védié; Heiner Boeing; Rudolf Kaaks; Verena Katzke; Christina Bamia; Androniki Naska; Antonia Trichopoulou; Franco Berrino; Giovanna Tagliabue; Domenico Palli; Salvatore Panico; Rosario Tumino; Carlotta Sacerdote; Petra H Peeters; H B As Bueno-de-Mesquita; Elisabete Weiderpass; Inger Torhild Gram; Guri Skeie; Maria-Dolores Chirlaque; Miguel Rodríguez-Barranco; Aurelio Barricarte; Jose Ramón Quirós; Miren Dorronsoro; Ingegerd Johansson; Malin Sund; Hanna Sternby; Kathryn E Bradbury; Nick Wareham; Elio Riboli; Marc Gunter; Paul Brennan; Eric J Duell; Pietro Ferrari
Journal:  Int J Cancer       Date:  2018-03-30       Impact factor: 7.396

6.  Aryl Hydrocarbon Receptor Ligands in Cigarette Smoke Induce Production of Interleukin-22 to Promote Pancreatic Fibrosis in Models of Chronic Pancreatitis.

Authors:  Jing Xue; Qinglan Zhao; Vishal Sharma; Linh P Nguyen; Yvonne N Lee; Kim L Pham; Mouad Edderkaoui; Stephen J Pandol; Walter Park; Aida Habtezion
Journal:  Gastroenterology       Date:  2016-10-18       Impact factor: 22.682

Review 7.  Pancreatic stellate cell: Pandora's box for pancreatic disease biology.

Authors:  Ratnakar R Bynigeri; Aparna Jakkampudi; Ramaiah Jangala; Chivukula Subramanyam; Mitnala Sasikala; G Venkat Rao; D Nageshwar Reddy; Rupjyoti Talukdar
Journal:  World J Gastroenterol       Date:  2017-01-21       Impact factor: 5.742

Review 8.  What Do We Currently Know about the Pathophysiology of Alcoholic Pancreatitis: A Brief Review.

Authors:  Michał Żorniak; Simon Sirtl; Julia Mayerle; Georg Beyer
Journal:  Visc Med       Date:  2020-06-10

9.  Targeting the HGF/c-MET pathway: stromal remodelling in pancreatic cancer.

Authors:  Srinivasa P Pothula; Zhihong Xu; David Goldstein; Neil Merrett; Romano C Pirola; Jeremy S Wilson; Minoti V Apte
Journal:  Oncotarget       Date:  2017-09-11

Review 10.  Uniting Epidemiology and Experimental Disease Models for Alcohol-Related Pancreatic Disease.

Authors:  Veronica Wendy Setiawan; Kristine Monroe; Aurelia Lugea; Dhiraj Yadav; Stephen Pandol
Journal:  Alcohol Res       Date:  2017
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.